Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype

Journal of Bone Oncology · Published 2026-02-21 · DOI 10.1016/j.jbo.2026.100754

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jbo.2026.100754

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Post-operative survival and use of systemic therapy in metastatic long-bone disease: 12 years of institutional experience · Journal of Bone Oncology · 2026 · Same journal
Risk of fracture among lung cancer survivors by cancer treatment modality: A population-based retrospective cohort study · Journal of Bone Oncology · 2026 · Same journal
Assessing the mechanism of osteosarcoma induced by long-term PET exposure: prediction from combined network toxicology, machine learning and molecular docking · Journal of Bone Oncology · 2025 · Same journal
Opinion statement regarding the use of post-operative radiotherapy after surgery for pathological fractures of the long bones: An answer to the points raised regarding methodology and analysis · Journal of Bone Oncology · 2026 · Same journal
LL-37 inhibits osteosarcoma progression by suppressing SQLE-mediated cholesterol synthesis via the PTEN/AKT/mTOR pathway · Journal of Bone Oncology · 2026 · Same journal
Clinically aligned whole-body MRI segmentation of skeletal metastases via Supervised Anatomical Pretraining · Journal of Bone Oncology · 2026 · Same journal
Mri-based habitat and peritumoral radiomics for predicting the proliferative activity of stromal cells in giant cell tumor of bone · Journal of Bone Oncology · 2025 · Same journal
Risk factors and clinical impact of bone pain in patients with multiple myeloma – A prospective interdisciplinary study · Journal of Bone Oncology · 2026 · Same journal
Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants · Journal of Bone Oncology · 2025 · Same journal
Alteration of bone architecture following androgen deprivation therapy in patients with prostate cancer using 3D-modeling from hip DXA · Journal of Bone Oncology · 2025 · Same journal